PMID 10630172
It is also a significant risk factor for various cardiovascular conditions
However, as noted by Mahiques-Santos, while melanotan II has been investigated as a potential ED treatment, it has been largely superseded by a nasally administered molecule (PT-141, Palatin Technologies), an active metabolite of the molecule [1]
The coprimary end points were the relative change in body weight and a reduction of 5% or more in body weight from baseline to week 68 with cagrilintidesemaglutide as compared with placebo
While glutathione has been studied for its potential health benefits, its effects can vary from person to person, and it should not replace medical treatments or be considered a cure for any disease
They are subject to strict FDA controls, extensive patent protection, and active monitoring by regulators